Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Dr Reddy

      Dr Reddy's to buy eight ANDAs in US for $350 million

      savita thakur thakur12 Jun 2016 4:13 PM IST
      New Delhi : Dr Reddy's Laboratories has inked a pact with Teva Pharmaceutical and an affiliate of Allergan Plc to buy a portfolio of eight abbreviated...
      FDA seeks suspension of 4,402 illegal prescription drug websites

      FDA seeks suspension of 4,402 illegal prescription drug websites

      savita thakur thakur12 Jun 2016 4:13 PM IST
      New York : The U.S. Food and Drug Administration said on Thursday it, along with international authorities, has formally sought to suspend 4,402...
      Amgen says migraine prevention drug meets main goal of study

      Amgen says migraine prevention drug meets main goal of study

      savita thakur thakur11 Jun 2016 4:32 PM IST
      An experimental drug for prevention of chronic migraine headaches from Amgen Inc met the main goal of a midstage study by reducing the number of...
      Valeant pays $54 million to settle US kickback, fraud claims

      Valeant pays $54 million to settle US kickback, fraud claims

      savita thakur thakur11 Jun 2016 4:31 PM IST
      New York : Valeant Pharmaceuticals International Inc will pay $54 million to settle civil charges that its Salix unit paid illegal kickbacks to induce...
      EU wants more transparency on AbbVies Humira, worlds top drug

      EU wants more transparency on AbbVie's Humira, world's top drug

      savita thakur thakur11 Jun 2016 4:30 PM IST
      London : Details of clinical trials involving AbbVie's rheumatoid arthritis drug Humira, the world's top-selling prescription medicine, are still...
      Too many drugmakers chasing same cancer strategy :USFDA

      Too many drugmakers chasing same cancer strategy :USFDA

      savita thakur thakur11 Jun 2016 4:30 PM IST
      Chicago : A new type of cancer drug that takes the brakes off the body's immune system has given drugmakers some remarkable wins against the deadly...
      Granules acquires rights for 4 products from US pharma Windlas

      Granules acquires rights for 4 products from US pharma Windlas

      savita thakur thakur10 Jun 2016 4:20 PM IST
      New Delhi : Pharma firm Granules India said its subsidiary has entered into a product in-licensing pact with US pharma Windlas, LLC to market and...
      Dr Lal PathLabs eyes wider footprint to drive growth

      Dr Lal PathLabs eyes wider footprint to drive growth

      savita thakur thakur10 Jun 2016 4:19 PM IST
      New Delhi : Diagnostic services provider Dr Lal PathLabs is looking at expanding its presence pan-India to be a key driver for the next phase of...
      BRIEF-Sanofi files investor presentation with SEC on proposed acquisition of Medivation

      BRIEF-Sanofi files investor presentation with SEC on proposed acquisition of Medivation

      savita thakur thakur10 Jun 2016 4:17 PM IST
      Sanofi says filed investor presentation on proposed acquisition of Medivation with the U.S. Securities and Exchange Commission* Sanofi says its...
      Colombia to set new price for Novartis cancer drug

      Colombia to set new price for Novartis cancer drug

      savita thakur thakur10 Jun 2016 4:17 PM IST
      Bogota : Colombia will set a new price for the Novartis cancer drug imatinib in a bid to cut healthcare costs after price negotiations with the Swiss...
      Government to develop six bulk drugs, medical devices parks

      Government to develop six bulk drugs, medical devices parks

      savita thakur thakur9 Jun 2016 11:50 AM IST
      NEW DELHI: To reduce import dependence, the government has decided to establish six bulk drug and medical devices parks, which will entail a combined...
      Zydus gets FDA nod for phase II clinical trial of Saroglitazar

      Zydus gets FDA nod for phase II clinical trial of Saroglitazar

      savita thakur thakur9 Jun 2016 11:48 AM IST
      NEW DELHI: Drug firm Zydus Cadila said it has received approval from the US health regulator to initiate a phase II clinical trial of Saroglitazar in...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok